Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KORU Medical SystemsKRMD -1.17%77 Days Inventory is 82.05 as of Mar. 2026, which is 16% below its 10-year median of 97.55. GuruFocus rates KRMD with a GF Score™ of 77/100 and a GF Value™ of $4.09 (Fairly Valued). Among 788 Medical Devices & Instruments companies, KORU Medical Systems ranks better than 84.39% on this metric.
The historical rank and industry rank for KORU Medical Systems's Days Inventory or its related term are showing as below:
KRMD'
s Days Inventory Range Over the Past 10 Years
Min: 76.21 Med: 97.55 Max: 242.88
Current: 87.74
During the past 13 years, KORU Medical Systems's highest Days Inventory was 242.88. The lowest was 76.21. And the median was 97.55.
KRMD's Days Inventory is ranked better than 84.39% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs KRMD: 87.74
Inventory Turnover measures how fast the company turns over its inventory within a year.
KORU Medical Systems's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
KORU Medical Systems's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.35.
KORU Medical Systems (NAS:KRMD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
KORU Medical Systems's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
KORU Medical Systems's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
KORU Medical Systems Days Inventory Related Terms
KORU Medical Systems Days Inventory Historical Data
* Premium members only.
The historical data trend for KORU Medical Systems's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KRMD vs EMBC, PDEX, SMTI: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KORU Medical Systems Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Days Inventory distribution charts can be found below:
* The bar in red indicates where KORU Medical Systems's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KORU Medical Systems (KRMD) has a Days Inventory of 82.05 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on KORU Medical Systems and its competitors. This is 16% below median its historical median of 97.55. Over the past decade, KORU Medical Systems' Days Inventory has ranged from 76.21 to 242.88. According to the industry distribution chart, KORU Medical Systems ranks #123 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 15.6%.
Is KORU Medical Systems' Days Inventory too high?
KORU Medical Systems' current Days Inventory of 82.05 is 16% below median its 10-year median of 97.55. Over the past 10 years, this metric has ranged from a low of 76.21 to a high of 242.88. The Medical Devices & Instruments industry median Days Inventory is 179.12. KORU Medical Systems' value of 82.05 is 54.2% below this industry median. Based on the distribution chart, KORU Medical Systems ranks #123 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, KORU Medical Systems has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Days Inventory compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #123 out of 788 companies for Days Inventory. This places KORU Medical Systems in the top 16% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.12. KORU Medical Systems' value of 82.05 is 54.2% below this benchmark. Historically, KORU Medical Systems' own Days Inventory has ranged from 76.21 to 242.88 over the past decade. While the company's 10-year median is 97.55 vs. the industry median of 179.12, KORU Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KORU Medical Systems's current Days Inventory of 82.05 is 54.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on KORU Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current Days Inventory is 82.05, which is 16% below median its own 10-year median of 97.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.09, compared to a current price of $4.23 — trading 3.4% above its estimated fair value. The current Days Inventory is 82.05, which is 16% below median its 10-year median of 97.55 and 54.2% below the Medical Devices & Instruments industry median of 179.12. KORU Medical Systems' overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Days Inventory is 82.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KORU Medical Systems (KRMD) Overvalued in 2026?
Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued.
The current stock price of $4.23 is trading 3.4% above its estimated GF Value™ of $4.09.
GuruFocus considers KORU Medical Systems to be Fairly Valued.
Key valuation signals for KRMD:
Days Inventory: 82.05 (16% below median its 10-year median of 97.55)
GF Value™: $4.09 vs. price of $4.23 (3.4% above fair value)
Industry Position: 54.2% below the Medical Devices & Instruments median (#123 of 788)
No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
77GF Score
Get the complete analysis for KRMD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRMD has been successfully added to your 
